Theravance Bio: 4Q Earnings Snapshot
GEORGE TOWN, Cayman Islands (AP) _ Theravance Biopharma Inc. (TBPH) on Monday reported a loss of $65.6 million in its fourth quarter.
On a per-share basis, the George Town, Cayman Islands-based company said it had a loss of $1.17.
The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of $1.11 per share.
The biopharmaceutical company posted revenue of $29.5 million in the period, exceeding Street forecasts. Four analysts surveyed by Zacks expected $18.3 million.
For the year, the company reported that its loss widened to $236.5 million, or $4.25 per share. Revenue was reported as $73.4 million.
Theravance Bio shares have decreased 9% since the beginning of the year. In the final minutes of trading on Monday, shares hit $23.51, a fall of 7% in the last 12 months.